$RXRX news
The latest RXRX stock news: headlines, filings, AI summaries and sentiment for $RXRX, updated around the clock.
- Recursion Pharmaceuticals Reports Q3 2026 Revenue Growth and Clinical Progress
- Short Interest Trends Reveal Divergent Sentiment in Mid- to Mega-Cap Healthcare Stocks
- Recursion Pharmaceuticals Reports Q3 Revenue Beat Amid GAAP EPS Miss
- RECURSION PHARMACEUTICALS, INC. - 10-Q Filing
- RECURSION PHARMACEUTICALS, INC. - 8-K Filing
- Cathie Wood's Ark Invest Adjusts Portfolio with New AI, Tech, Biotech Investments
- Short Interest Data Reveals Investor Sentiment in Healthcare Sector
- HubSpot Rises 29 Places in Roundtable 100 Power Ranking
- Goldman Sachs Assigns $75 Target to Tempus AI, But Data Business Faces Renewal Risks
- RECURSION PHARMACEUTICALS, INC. - 8-K Filing
- Palantir and Rocket Lab Rise Sharply in Roundtable 100 Power Ranking
- MindWalk Unveils Biological Context Layer for AI Drug Discovery at AMD Event
- Short Interest in Healthcare Stocks Shows Bearish Sentiment Toward Biotech Firms
- Morgan Stanley Raises Price Target on Recursion Pharmaceuticals (RXRX)
- Recursion Pharmaceuticals Reports Q1 2026 Earnings and Provides Business Update